Guest: Sergio Baranzini, PhD In a landmark study involving over 10,000 patients, the International MS Genetics Consortium (IMSGC) has identified the first genetic variant associated with disease severity in multiple sclerosis (MS). Dr. Sergio Baranzini, a Distinguished Professor of Neurology at the University of California, San Francisco Weill Institute for Neurosciences, explains what's next in researching this variant and working towards effective treatments. Dr. Baranzini

Guest: Michael Levy, MD, PhD Antibody-mediated demyelinating diseases, such as neuromyelitis optica spectrum disorder and MOG antibody disease, differ fundamentally from multiple sclerosis (MS) due to their association with specific antibodies. Dr. Michael Levy explains how these conditions progress, how relapses can drive disability, and why prevention is critical for improving long-term outcomes. Dr. Levy is an Associate Professor at Harvard Medical School working in the

Guest: Le Hua, MD Diagnosing multiple sclerosis (MS) in older patients presents unique challenges, especially as age-related comorbidities and common neurological findings often mimic MS. Hear from Dr. Le Hua as she highlights the importance of thorough clinical history, cautious interpretation of imaging, and the role of paraclinical studies in ensuring accurate MS diagnosis, particularly in patients over 50. Dr. Hua is the Director of Clinical Operations and Director of the Multiple

Guest: Michael Levy, MD, PhD Antibody-mediated demyelinating diseases, such as neuromyelitis optica spectrum disorder and MOG antibody disease, differ fundamentally from multiple sclerosis (MS) due to their association with specific antibodies. Dr. Michael Levy explains how these conditions progress, how relapses can drive disability, and why prevention is critical for improving long-term outcomes. Dr. Levy is an Associate Professor at Harvard Medical School working in the

Guest: Sergio Baranzini, PhD In a landmark study involving over 10,000 patients, the International MS Genetics Consortium (IMSGC) has identified the first genetic variant associated with disease severity in multiple sclerosis (MS). Dr. Sergio Baranzini, a Distinguished Professor of Neurology at the University of California, San Francisco Weill Institute for Neurosciences, explains what's next in researching this variant and working towards effective treatments. Dr. Baranzini

Guest: Le Hua, MD Diagnosing multiple sclerosis (MS) in older patients presents unique challenges, especially as age-related comorbidities and common neurological findings often mimic MS. Hear from Dr. Le Hua as she highlights the importance of thorough clinical history, cautious interpretation of imaging, and the role of paraclinical studies in ensuring accurate MS diagnosis, particularly in patients over 50. Dr. Hua is the Director of Clinical Operations and Director of the Multiple

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David Levinthal, MD, PhD Cyclic vomiting syndrome (CVS) is often underdiagnosed in adults due to its episodic nature and symptom overlap with other conditions. Dr. David Levinthal joins Dr. Peter Buch to explore key diagnostic criteria, key differences between CVS and cannabinoid hyperemesis syndrome (CHS), and evidence-based treatment strategies. Dr. Levinthal is the Director of the UPMC Neurogastroenterology and Motility Center and

In this episode 32 of The League, hosts David Magid and Benoy Thanjan (Reneu Energy, Solar Maverick Podcast) break down the biggest solar and clean energy headlines of the week. Topics we cover today: Solar for All Terminated: The Trump administration halts the $7B program, impacting nearly 1M low-income households. Legal challenges are expected. U.S. Solar Growth Slows: Utility-scale solar grew just 10% in mid-2025 vs. mid-2024 — a sharp drop from the 33% growth seen the prior year. Texas

Substance-Related and Addictive Disorders Alcohol Use Disorder Definition/Overview Clinical Presentation Labs, Studies, and Physical Exam Findings Treatment Key Differentiators Test Alert Opioid Use Disorder Definition/Overview Clinical Presentation Labs, Studies, and Physical Exam Findings Treatment Key Differentiators Test Alert Stimulant Use Disorder (Cocaine, Amphetamines) Definition/Overview Clinical Presentation Labs, Studies, and Physical Exam Findings Treatment Key Differentiators

Solar Made Simple, brought to you by Kevenergy, is predicated on the responsibilities and rights inherent in us all to take part in the conversation and not just ‘Talk the Talk ' but ‘Walk the Walk'.

Discover how adopting a secular worldview and positive humanism can boost creativity, personal flourishing, and meaningful growth.

In a time when many diagnostics companies are struggling, GeneDx is thriving by focusing squarely on solving one of medicine’s most pressing problems: the diagnostic odyssey for rare disease. CEO Katherine Stueland explains why the company has committed to whole exome and genome testing as first-line answers for children, and how their recent acquisition of Fabric Genomics expands their reach into AI-powered interpretation services.* 0:00 Success coming from a focus on rare disease* 5:20 Why whole

For primary care clinicians, a top risk area is related to allegations of delayed diagnosis of cancer. Data in the Harvard system show that the top three cancers in primary care litigation are prostate, lung, and breast cancer. Harvard’s Marc Garnick, MD is a national expert on prostate cancer and liability sharing how to communicate with patients about risks and benefits of testing and interventions to minimize allegations of negligence.

Listen to Ep. 131 Future Now Show‘Love, Turkey, and visionary architecture’ with Minimalist Tadd van Patton, ‘Seeing Life as it is..” with Richard Thaddeus Van PettenCray, “Perfection is the enemy of the Good,” with Greg Panos I knew Thaddeus when he became a housemate of mine in the late 1980’s, 19 years old, raised in Santa Cruz, ready for whatever’s next, which included me..An inquistive, kind, and thoughtful person, I helped connect him with his

Eye On The Night Sky For Friday, September 26

Discover the universal human bond and how positive humanism offers a secular path to personal flourishing and meaningful human connection.

CME credits: 1.00Valid until: 19-09-2026 Claim your CME credit at https://reachmd.com/programs/cme/emerging-therapies-in-managing-adult-and-pediatric-patients-with-fsgs-latest-data/37186/ Managing patients with focal segmental glomerulosclerosis, or FSGS, can present certain challenges. FSGS is a serious, progressive condition that has no current FDA-approved treatment and standard of care therapy may not meet treatment goals for many patients. But the current use of patient-reported

World leaders will convene at a climate summit hosted by UN Secretary-General Antonio Guterres on Wednesday in New York. Countries face mounting pressure to set more ambitious emission reduction targets for 2035 ahead of COP30 in Brazil. Governments were invited to submit their updated pledges by February 2025. Of the 195 Paris Agreement signatories, only 13 countries have met the deadline, while a total of 37 have submitted new plans. FRANCE 24’s Valérie Dekimpe explains.

Send us a text Join host Dr. Stephanie Ihnow for a conversation with the new SRS President, Dr. Suken Shah. They discuss his vision for the year ahead, the guiding motto shaping his presidency, and exciting details about the next Annual Meeting in Sydney, Australia. * The Scoliosis Research Society (SRS) podcast is aimed at delivering the most current and trusted information to clinicians that care for patients with scoliosis and other spinal conditions. From news in the world of spin...

Eye On The Night Sky For Thursday, September 25